Capecitabine API

Name of Product	Capecitabine API
CAS No	154361‑50‑9
Therapeutic use:-	Oral prodrug of 5‑fluorouracil; antimetabolite (fluoropyrimidine) used in breast, colorectal, gastric cancer
Grade	IP/USP
Form:-	API Powder
Status	Commercial

Product Overview

Capecitabine API is a chemotherapy drug. It belongs to the fluoropyrimidine carbamate class.

The product is a prodrug. It gets converted into 5-fluorouracil (5-FU) in the body.

It specifically targets tumour tissues with higher thymidine phosphorylase activity.

Capecitabine API is used in oncology because it targets tumors effectively.

Its oral dosage form makes it convenient.

Treatment of colorectal cancer in metastatic and advanced stages.
Effective in breast cancer treatment.
Useful as part of gastric cancer control and for advanced gastric carcinoma.
Capecitabine is also being investigated in various cancers where fluoropyrimidine treatment is beneficial.

Available in secure, pharmaceutical-grade HDPE bottles, aluminium foil bags, and fiber drums.

Store at 2–8°C in a cool, dry place, protected from light and moisture.

Capecitabine is made in GMP- and ISO-certified facilities. This guarantees top pharma-grade quality.

We offer a global supply chain with complete compliance and regulations.

We ensure uncompromised quality with each batch, meeting international pharmacopeia standards.

Our team specializes in providing technical and regulatory support.